» Articles » PMID: 12753535

COPD Prevalence in 12 Asia-Pacific Countries and Regions: Projections Based on the COPD Prevalence Estimation Model

Overview
Journal Respirology
Specialty Pulmonary Medicine
Date 2003 May 20
PMID 12753535
Citations 50
Affiliations
Soon will be listed here.
Abstract

Objective: COPD is a leading cause of mortality and morbidity worldwide. Despite the high rates of cigarette smoking, and the wide use of biomass fuels, there is very little objective data on the prevalence of COPD in Asia.

Methodology: We used a COPD prevalence model to estimate the prevalence of COPD in 12 Asian countries. This model is a validated, computerized tool that uses epidemiological relationships and risk factor prevalence to project the prevalence of COPD within a given population aged 30 years and older.

Results: The total number of moderate to severe COPD cases in the 12 countries of this region, as projected by the model, is 56.6 million with an overall prevalence rate of 6.3%. The COPD prevalence rates for the individual countries range from 3.5% (Hong Kong and Singapore) to 6.7% (Vietnam).

Conclusions: The COPD prevalence rates projected by the model reflect the high prevalence of the risk factors for the disease in Asia. The combined prevalence of 6.3% for these countries is considerably higher than the overall rate of 3.8% as extrapolated from WHO data for this region. These estimates highlight the need for further epidemiological studies to support appropriate allocation of resources for the prevention and management of COPD.

Citing Articles

User-centred design of ChestCare: mHealth app for pulmonary rehabilitation for patients with COPD; a mixed-methods sequential approach.

Ghaben S, Mat Ludin A, Mohamad Ali N, Singh D Digit Health. 2025; 11():20552076241307476.

PMID: 39839963 PMC: 11748081. DOI: 10.1177/20552076241307476.


Impact of Aerobika oscillating positive expiratory pressure in improving small airway resistance, lung function, symptoms and exercise capacity in chronic obstructive pulmonary disease.

Sahardin S, Jailaini M, Abeed N, Ban A, Hau N, Azmel A Front Med (Lausanne). 2023; 10:1202380.

PMID: 37332765 PMC: 10272579. DOI: 10.3389/fmed.2023.1202380.


Investigation and Analysis of Risk Factors and Psychological Status of Chronic Obstructive Pulmonary Disease in Permanent Residents Aged 40 or Older in Hongyuan County, Aba Prefecture, Sichuan Province.

Xia J, Zou X, Qiu Y, Li W, Huang L, Xie W Int J Chron Obstruct Pulmon Dis. 2023; 18:827-835.

PMID: 37193039 PMC: 10183191. DOI: 10.2147/COPD.S399279.


Changes in Serum Immunoglobulin G Subclasses during the Treatment of Patients with Chronic Obstructive Pulmonary Disease with Infectious Exacerbations.

Ta T, Viet T, Xuan Nguyen K, Hai Nguyen C, Ngoc Vu H, Le T Adv Respir Med. 2022; 90(6):500-510.

PMID: 36547011 PMC: 9774113. DOI: 10.3390/arm90060056.


Symptom clusters, associated factors and health-related quality of life in patients with chronic obstructive pulmonary disease: A structural equation modelling analysis.

Fei F, Siegert R, Zhang X, Gao W, Koffman J J Clin Nurs. 2022; 32(1-2):298-310.

PMID: 35098602 PMC: 10078635. DOI: 10.1111/jocn.16234.